These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16266752)

  • 1. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
    Soriano JM; González L; Catalá AI
    Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
    Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
    Turner PC; Nikiema P; Wild CP
    Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
    Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
    J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice.
    Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP
    Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
    Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides).
    Voss KA; Howard PC; Riley RT; Sharma RP; Bucci TJ; Lorentzen RJ
    Cancer Detect Prev; 2002; 26(1):1-9. PubMed ID: 12088196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
    Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
    Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
    Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material.
    Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ
    Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
    Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
    J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumonisin toxicity and metabolism studies at the USDA. Fumonisin toxicity and metabolism.
    Norred WP; Voss KA; Riley RT; Plattner RD
    Adv Exp Med Biol; 1996; 392():225-36. PubMed ID: 8850620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
    Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
    Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
    J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of urinary sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children.
    Wangia RN; Githanga DP; Xue KS; Tang L; Anzala OA; Wang JS
    Biomarkers; 2019 Jun; 24(4):379-388. PubMed ID: 30821509
    [No Abstract]   [Full Text] [Related]  

  • 20. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.